Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by autonomic failure, parkinsonism, and cerebellar ataxia [3] . The striatonigral and olivopontocerebellar systems are most vulnerable regions in MSA. A variable degree of neuronal loss and astrogliosis are observed in addition to glial cytoplasmic inclusions (GCIs). "Minimal change" or "preclinical" MSA has been reported to as an early pathologic form of MSA [2, [4] [5] [6] [7] . These cases have minimal neuronal loss confined to the striatonigral and/ or olivopontocerebellar systems [2, [5] [6] [7] . Some have no neuronal loss [4] , but GCIs are observed throughout the brain, even in regions without neuronal loss. This finding suggests that the formation of GCI may precede neuronal loss, and both striatonigral and olivopontocerebellar systems are the brain regions affected in the earliest stage of the disease. We herein report a limbic counterpart of "minimal change" MSA with abundant α-synuclein pathology in the limbic system. This patient was a 70-year-old Caucasian man who had a medical history of depression and anxiety for more than 20 years. He noticed bilateral arm stiffness and difficulty with swallowing at age 65. 1 year later, he was evaluated by a neurologist and found to have slow gait, with multi-step pivot, and rigidity in his arms. He also developed imbalance and leg stiffness, which caused multiple falls. He was on a feeding tube because he could not swallow. On neurological examination at age 69, moderate hypophonia, hypomimia, bradykinesia in his arms, moderate symmetric rigidity in the four extremities, shuffling gait with decreased arm swing, and mild retropulsion were observed. Because of the 1-year history of taking olanzapine, drug-induced parkinsonism was suspected; however, his symptoms did not improve after discontinuing olanzapine. He was diagnosed with Parkinson disease and started taking carbidopa-levodopa, but discontinued because of intolerance. He developed a head drop at age 70. A suprapubic catheter was inserted for bladder dysfunction. Based on symmetrical parkinsonism without tremor, dysphagia, head drop, constipation, bladder dysfunction, and the absence of cognitive decline, he was given a diagnosis of MSA.
At autopsy, the brain had no atrophy (fixed brain weight was 1140 g). The substantia nigra and locus coeruleus had a normal degree of pigmentation. On hematoxylin and eosin-stained sections, no neuronal loss or gliosis were observed throughout the brain, except the substantia nigra where rare extraneuronal deposits of pigment indicated minimal neuronal loss. Microgliosis was not observed on IBA-1-immunostained sections in all brain regions. Immunohistochemistry for α-synuclein revealed that GCIs and neuronal cytoplasmic inclusions (NCIs) distributed throughout the brain ( Table 1) . The limbic structures, especially hippocampus, were most severely affected; by contrast, the striatonigral and olivopontocerebellar systems had only sparse inclusions. NCIs in the dentate gyrus were ring-shaped. Pick body-like NCIs, which are thought to correlate with neuronal loss, were not detected [1] . Neuronal intranuclear inclusions were rare in the hippocampal pyramidal layer, substantia nigra, pontine base, and inferior olivary nucleus. Representative images are given in Supplementary Fig. 1 . Although neurodegenerative changes in striatonigral or olivopontocerebellar systems were minimal, considering the specificity of GCIs to MSA, the neuropathologic diagnosis of "minimal change" MSA was made. On thioflavin S microscopy, Alzheimer'stype pathology was minimal (Braak neurofibrillary tangle stage III; Thal amyloid phase 0). No pathological TDP-43 aggregates were observed in the amygdala, hippocampus, striatum, and midbrain. Antibodies and staining conditions are summarized in Supplementary Table 1. The present case showed an unusual distribution of α-synuclein pathology. Limbic structures, especially components of the Papez circuit (i.e., the hippocampus, fornix, mammillothalamic tract, and anterior thalamic nuclei), were predominantly affected while striatonigral and olivopontocerebellar systems were less affected. To characterize the distribution pattern of GCIs, we quantified the burden of GCIs in white matter regions of 184 MSA cases in the Mayo Clinic brain bank and compared to this patient ( Supplementary Fig. 2 ).
Some MSA patients have limbic-predominant α-synuclein pathology with neuronal loss and dementia, abnormal behavior, or corticobasal syndrome [1] ; however, this patient did not have any of these symptoms possibly because of the absence of neuronal loss in the limbic system. On the other hand, the patient developed parkinsonism and autonomic dysfunction despite minimal neuronal loss in the substantia nigra. Moreover, immunohistochemistry for tyrosine hydroxylase did not detect dopaminergic degeneration in the substantia nigra or the dorsolateral putamen (Supplementary Fig. 3 ). The neuropathological substrate of his symptoms remains unclear; α-synuclein aggregates may lead to neuronal dysfunction sufficient to cause these symptoms even without apparent neuronal loss [5] . The present case implies that not only the striatonigral or olivopontocerebellar systems, but also the limbic system can be affected predominantly by α-synuclein pathology in "minimal change" MSA.
